This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Agouron Pharmaceuticals, Inc., Amgen Fremont Inc.. Active years: 2010.
Company Filing History:
1 out of 174 
1 out of 78 Years Active: 2010
Title: Eva Rose Chin: Innovator in Myostatin Antibodies
Introduction
Eva Rose Chin is a prominent inventor based in Mystic, CT (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting myostatin. Her innovative work has the potential to impact various therapeutic applications.
Latest Patents
Eva Rose Chin holds 1 patent related to her invention of antibodies that bind to myostatin. This invention includes human antibodies and antigen-binding portions that function to inhibit myostatin. The patent also covers chimeric, bispecific, and single-chain antibodies, as well as methods for producing these antibodies. Additionally, it encompasses gene therapy methods using nucleic acid molecules encoding the immunoglobulin molecules derived from human anti-myostatin antibodies.
Career Highlights
Throughout her career, Eva has worked with notable companies such as Amgen Fremont Inc. and Agouron Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in the field of antibody development and biotechnology.
Collaborations
Eva has collaborated with esteemed colleagues, including Larry L Green and Chikwendu Ibebunjo. These partnerships have further enhanced her research and development efforts in the biotechnology sector.
Conclusion
Eva Rose Chin is a trailblazer in the field of myostatin antibodies, with a patent that showcases her innovative spirit and dedication to advancing biotechnology. Her work continues to pave the way for new therapeutic possibilities.